prostacyclin
PubChem Notes:
Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
Molecular Formula:
C20H32O5
InChI: InChI=1/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8u/t14-,16+,17+,18+,19-/m0/s1/f/h23H
InChIKey: InChIKey=KAQKFAOMNZTLHT-XATQXTRFDL
SMILES: CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O
Names:
C01312
epoprostenol
PGI2
prostacyclin
prostaglandin I2
(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate
35121-78-9
5-[(1R,5S,7R,8S)-7-hydroxy-8-[(E,3S)-3-hydroxyoct-1-enyl]-4-oxabicyclo[3.3.0]oct-3-ylidene]pentanoic acid
Registries:
PubChem CID 5280427
PubChem ID 4527
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|